February 12, 2016—The Georgia Department of Community Health (DCH) has postponed implementation of a new policy for 340B claims identification. … [Read more...]
Amgen Providing 340B Refunds on Most of Its Products
Price restatements include Enbrel, Neulasta, and ProliaFebruary 12, 2016—Amgen, the world's largest biotechnology company by revenue, is giving 340B covered entities refunds stemming from "an adjustment of its 340B ceiling price" on nine of its 16 products, including its blockbusters Enbrel, Neulasta, and Prolia. … [Read more...]
Study: Medicare Pays 340B Hospitals Less for Part B Drugs
DSH hospitals also treat more vulnerable patients than other providersFebruary 11, 2016—Medicare pays disproportionate share hospitals in the 340B drug discount program 13 percent less on average for separately payable drugs reimbursed through Medicare Part B than it pays other hospitals and physician practices in the Part B market, researchers have found. The new study also shows that 340B DSH hospitals are treating more vulnerable patients than … [Read more...]
“Pharma bro” Company’s Excuse: 340B Made Me Do It
The 340B program came up at last week's House Oversight committee hearing about drug company price gouging – the hearing during which ex-Turing Pharmaceuticals CEO Martin Shkreli pleaded the Fifth Amendment and tweeted that the committee members were imbeciles. Shkreli and Turing Chief Commercial Officer Nancy Retzlaff were there to explain why Turing raised the cost of the … [Read more...]
340B Recertification for Most Federal Grantees Rescheduled for Feb. 12
Process was originally set to start Jan. 27February 10, 2016—Annual recertification of eligibility for most federal grantees in the 340B drug discount program will begin Friday Feb. 12, and end Wednesday March 9, the Health Resources and Services Administration announced today. … [Read more...]
More Than 4,700 Physicians Urge Congress to Protect 340B
Drug discount program "helps us take better care of our patients every day"February 10, 2016— More than 4,700 physicians at safety-net hospitals across America have signed a letter to the Republican and Democratic leaders of Congress urging them not to limit or shrink the 340B drug discount program. … [Read more...]
President Seeks Express Rulemaking Power for 340B Program
Asks Congress to amend 340B statute in his annual budget requestFebruary 9, 2016—The Obama administration today asked Congress in its fiscal year 2017 budget request to amend the 340B statute to give the Secretary of Health and Human Services express authority to "issue regulations with binding and future effect" for the drug discount program. The administration is seeking $26.24 million for the 340B program – $17.24 million in … [Read more...]